Advertisement
Screener

Exelixis Inc (EXEL) ROE

Exelixis Inc (EXEL) ROE

  • 2026-07-03: ROE 46.68%.
  • 2026-04-03: ROE 43.05%.
  • 2026-01-02: ROE 36.21%.
  • 2025-10-03: ROE 31.37%.

Complete source-backed roe history.

Available history
2009-12-31 to 2026-07-03
Data captured

Historical ROE

DateROE
2026-07-0346.68%
2026-04-0343.05%
2026-01-0236.21%
2025-10-0331.37%
2025-07-0429.62%
2025-04-0430.20%
2025-01-0323.23%
2024-09-2720.52%
2024-06-2816.51%
2024-03-299.64%
2023-12-299.18%
2023-09-293.92%
2023-06-306.50%
2023-03-316.02%
2022-12-307.33%
2022-09-3012.35%
2022-07-0111.40%
2022-04-0112.99%
2021-12-3110.45%
2021-10-017.78%
2021-07-024.60%
2021-04-023.39%
2021-01-015.95%
2020-10-028.21%
2020-07-0315.36%
2020-04-0316.81%
2020-01-0319.04%
2019-09-2738.18%
2019-06-2843.10%
2019-03-2946.93%
2018-12-2853.60%
2018-09-2840.23%
2018-06-2941.70%
2018-03-3047.33%
2017-12-2976.82%
2017-09-3082.58%
2017-06-3039.19%
2017-03-314.76%
2016-12-31-78.62%
2016-09-30-458.79%
2016-06-3097.33%
2016-03-31121.64%
2015-12-31117.64%
2015-09-30235.47%
2015-06-30101.92%
2015-03-31151.16%
2014-12-31164.00%
2014-09-30469.60%
2014-06-30-8613.35%
2014-03-31-375.03%
2013-12-31-1642.93%
2013-09-30-168.64%
2013-06-30-96.56%
2013-03-31-64.32%
2012-12-31-61.03%
2012-09-30-14.42%
2012-06-3062.11%
2012-03-3158.21%
2011-12-3183.52%
2011-09-30377.70%
2011-06-3091.59%

Annual ROE

DateROE
2026-01-0236.21%
2025-01-0323.23%
2023-12-299.18%
2022-12-307.33%
2021-12-3110.45%
2021-01-015.95%
2020-01-0319.04%
2018-12-2853.60%
2017-12-2954.12%
2016-12-31-78.62%
2016-12-30-78.62%
2016-01-01114.87%
2015-12-31114.87%
2014-12-31164.00%
2013-12-31-1642.93%
2012-12-31-61.03%
2011-12-3183.52%
2010-12-3140.44%
2009-12-3182.59%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78